Together for better liver cancer patient treatment and care
Liver cancer incidence rates are rapidly increasing across the world. And, because it is rarely detectable early, when it is most treatable, any liver cancer is difficult to cure.
ILCA’s mission is to lead a global community of physicians, scientists and allied professionals through education and research, with the goal to better prevent and treat liver cancer.
Our industry partnership programme for 2022 offers healthcare companies the platform from which to support ILCA’s mission and values through educational, scientific activities and events. We offer a strategic forum for high-level dialogue between ILCA leadership and industry partners to discuss the key issues for the future of liver cancer treatment, as well as recognition of your year-round partnership support.